MeSH term
Frequency | Condition_Probility | Embryonic and Fetal Development | 2 | 0.0 |
Humans | 95 | 0.0 |
Immunohistochemistry | 33 | 0.0 |
Molecular Weight | 4 | 0.0 |
Receptors, Nerve Growth Factor/analysis/*biosynthesis | 2 | 66.0 |
Adult | 14 | 0.0 |
Animals | 31 | 0.0 |
Female | 35 | 0.0 |
Membrane Glycoproteins/metabolism | 2 | 0.0 |
Rats | 7 | 0.0 |
Research Support, Non-U.S. Gov't | 60 | 0.0 |
Thiolester Hydrolases/*analysis | 2 | 28.0 |
Ubiquitin Thiolesterase | 3 | 2.0 |
*Apoptosis | 2 | 0.0 |
Carbazoles/pharmacology | 2 | 4.0 |
Receptor, trkA | 3 | 5.0 |
Tumor Cells, Cultured | 8 | 0.0 |
Cell Line | 13 | 0.0 |
Gene Expression | 3 | 0.0 |
Genetic Vectors | 3 | 0.0 |
Mice | 13 | 0.0 |
Mutation | 2 | 0.0 |
Phenotype | 4 | 0.0 |
Retroviridae/*genetics | 2 | 1.0 |
Choline O-Acetyltransferase/metabolism | 3 | 2.0 |
Base Sequence | 7 | 0.0 |
DNA Primers | 2 | 0.0 |
Phosphorylation | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 45 | 0.0 |
Flow Cytometry | 5 | 0.0 |
Neoplasm Transplantation | 3 | 0.0 |
Receptors, Nerve Growth Factor/*genetics | 4 | 12.0 |
Retroviridae/genetics | 2 | 0.0 |
Transfection | 4 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Time Factors | 3 | 0.0 |
*Virus Replication | 2 | 0.0 |
Comparative Study | 12 | 0.0 |
Statistics, Nonparametric | 2 | 0.0 |
Cell Division/physiology | 2 | 0.0 |
Infant, Newborn | 4 | 0.0 |
Receptors, Nerve Growth Factor/metabolism | 3 | 8.0 |
Transduction, Genetic | 2 | 0.0 |
Cells, Cultured | 4 | 0.0 |
Receptors, Nerve Growth Factor/physiology | 2 | 12.0 |
Biopsy | 2 | 0.0 |
Receptors, Nerve Growth Factor/*analysis | 9 | 60.0 |
Aged | 18 | 0.0 |
Male | 31 | 0.0 |
Middle Aged | 19 | 0.0 |
*Multigene Family | 2 | 0.0 |
Solubility | 2 | 0.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Receptor, Nerve Growth Factor | 3 | 10.0 |
Tissue Distribution | 2 | 0.0 |
Cell Division | 3 | 0.0 |
Nerve Growth Factors/metabolism | 8 | 13.0 |
Adolescent | 11 | 0.0 |
Nerve Fibers/*chemistry | 2 | 11.0 |
Chromosome Mapping | 3 | 0.0 |
Genetic Markers | 3 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
*Chromosome Mapping | 3 | 0.0 |
Crosses, Genetic | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Molecular Sequence Data | 5 | 0.0 |
*Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Antibodies, Monoclonal | 6 | 0.0 |
Immunoenzyme Techniques | 8 | 0.0 |
Receptors, Nerve Growth Factor/*metabolism | 6 | 13.0 |
Child | 11 | 0.0 |
English Abstract | 3 | 0.0 |
Spinal Cord Injuries/*metabolism | 2 | 22.0 |
*Nerve Growth Factors | 2 | 1.0 |
Regeneration/physiology | 2 | 11.0 |
Kinetics | 5 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 7 | 0.0 |
Blotting, Southern | 5 | 0.0 |
*Chromosomes, Human, Pair 17 | 5 | 0.0 |
Restriction Mapping | 3 | 0.0 |
Child, Preschool | 7 | 0.0 |
Infant | 6 | 0.0 |
Actins/metabolism | 2 | 0.0 |
Nerve Growth Factors/*pharmacology | 4 | 3.0 |
Signal Transduction | 2 | 0.0 |
Acetylcholine/*physiology | 2 | 11.0 |
Hamsters | 2 | 0.0 |
Aged, 80 and over | 8 | 0.0 |
Neoplasm Metastasis | 3 | 0.0 |
Diagnosis, Differential | 2 | 0.0 |
Acetylcholinesterase/metabolism | 2 | 2.0 |
Receptors, Nerve Growth Factor/analysis | 2 | 14.0 |
Nerve Growth Factors/*analysis | 3 | 20.0 |
Lod Score | 3 | 0.0 |
Microscopy, Electron | 5 | 0.0 |
Immunohistochemistry/methods | 5 | 0.0 |
Peptides/*metabolism | 2 | 1.0 |
Staining and Labeling | 4 | 0.0 |
Chromosome Disorders | 2 | 0.0 |
Cytopathogenic Effect, Viral | 2 | 1.0 |
Karyotyping | 2 | 0.0 |
Alleles | 3 | 0.0 |
DNA Probes | 2 | 0.0 |
*Genes, Structural | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Pedigree | 2 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
Gestational Age | 2 | 0.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Reference Values | 3 | 0.0 |
Ploidies | 2 | 0.0 |
Receptors, Cell Surface/*genetics | 5 | 1.0 |
Receptors, Nerve Growth Factor | 30 | 61.0 |
Fluorescent Antibody Technique | 4 | 0.0 |
In Vitro | 2 | 0.0 |
Nerve Growth Factors/*metabolism | 4 | 5.0 |
Receptors, Cell Surface/*metabolism | 4 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Chimera | 2 | 1.0 |
Neuroblastoma | 2 | 1.0 |
Receptors, Cell Surface/*analysis | 5 | 4.0 |
Receptors, Cell Surface/immunology/*metabolism | 2 | 6.0 |
Biological Markers/analysis | 2 | 0.0 |
Hyperplasia | 2 | 0.0 |
Receptors, Cell Surface/immunology/metabolism | 2 | 13.0 |
Antibodies, Monoclonal/diagnostic use | 5 | 0.0 |
Cats | 2 | 0.0 |
Cebus/anatomy & histology/*metabolism | 2 | 100.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Antigens, Neoplasm/immunology/metabolism | 2 | 20.0 |
Glial Fibrillary Acidic Protein/metabolism | 2 | 0.0 |
Receptors, Cell Surface/metabolism | 2 | 0.0 |
S100 Proteins/metabolism | 2 | 1.0 |
Cell Differentiation/*drug effects | 2 | 1.0 |
Nerve Growth Factors/metabolism/*pharmacology | 2 | 15.0 |
Receptors, Cell Surface/genetics/immunology/*metabolism | 2 | 20.0 |
Proto-Oncogene Proteins/genetics | 2 | 0.0 |
Receptors, Cell Surface/*genetics/metabolism | 2 | 2.0 |
Cell Membrane/metabolism | 2 | 0.0 |
*Linkage (Genetics) | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
